✦ LIBER ✦

168 The Long Term Efficacy and Safety of Rifaximin in the Maintenance of Remission From Overt Hepatic Encephalopathy in Cirrhotic Patients

✍ Scribed by Kevin D. Mullen; Arun J. Sanyal; Nathan M. Bass; Fred Poordad; Shirley Huang; Kunal Merchant; Enoch Bortey; William P. Forbes

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Rifaximin Is Safe and Well Tolerated for

✍ Mullen, Kevin D.; Sanyal, Arun J.; Bass, Nathan M.; Poordad, Fred F.; Sheikh, Mu 📂 Article 📅 2014 🏛 Elsevier Science 🌐 English ⚖ 704 KB

109 LONG TERM EFFICACY AND SURVIVAL IN P

✍ K.D. Mullen; F. Poordad; L. Rossaro; M. Jamal; J. Talwalkar; S. Huang; K. Mercha 📂 Article 📅 2011 🏛 Elsevier Science 🌐 English ⚖ 42 KB

144 The Effect of Prognostic Factors On

✍ Samuel Sigal; F. Fred Poordad; Kimberly L. Beavers; Kunal Merchant; Shirley Huan 📂 Article 📅 2009 🏛 Elsevier Science 🌐 English ⚖ 152 KB

Rifaximin in the treatment of chronic he

✍ D. Festi; G. Mazzella; M. Orsini; S. Sottili; A. Sangermano; S. Li Bassi; P. Par 📂 Article 📅 1993 🏛 Elsevier Science 🌐 English ⚖ 629 KB

MAINTENANCE OF REMISSION WITH INFLIXIMAB

✍ S. Nasoni; A. Petrolati; N. Altavilla; Z. Rossi 📂 Article 📅 2009 🏛 Elsevier Science 🌐 English ⚖ 69 KB

PA.160 MAINTENANCE OF REMISSION WITH INF

✍ A. Petrolati; S. Nasoni; N. Altavilla; R. Cipolla; P. Fenderico; G. Forlini; Z. 📂 Article 📅 2008 🏛 Elsevier Science 🌐 English ⚖ 66 KB